Cancer-associated thrombosis: the when, how and why

Carregando...
Imagem de Miniatura
Citações na Scopus
150
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
EUROPEAN RESPIRATORY SOC JOURNALS LTD
Citação
EUROPEAN RESPIRATORY REVIEW, v.28, n.151, article ID 180119, 11p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognised both for physicians that deal with venous thromboembolism (VTE) and for oncologists. It is currently estimated that the annual incidence of VTE in patients with cancer is 0.5% compared to 0.1% in the general population. Active cancer accounts for 20% of the overall incidence of VTE. Of note, VTE is the second most prevalent cause of death in cancer, second only to the progression of the disease, and cancer is the most prevalent cause of deaths in VTE patients. Nevertheless, CAT presents several peculiarities that distinguish it from other VTE, both in pathophysiology mechanisms, risk factors and especially in treatment, which need to be considered. CAT data will be reviewed in this review.
Palavras-chave
Referências
  1. Ades S, 2015, J THROMB HAEMOST, V13, P998, DOI 10.1111/jth.12910
  2. Agnelli G, 2018, THROMB HAEMOSTASIS, V118, P1668, DOI 10.1055/s-0038-1668523
  3. Agnelli G, 2012, NEW ENGL J MED, V366, P601, DOI 10.1056/NEJMoa1108898
  4. Agnelli G, 2009, LANCET ONCOL, V10, P943, DOI 10.1016/S1470-2045(09)70232-3
  5. Akl EA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006650.pub4
  6. Ay C, 2010, BLOOD, V116, P5377, DOI 10.1182/blood-2010-02-270116
  7. Blann AD, 2006, BRIT MED J, V332, P215, DOI 10.1136/bmj.332.7535.215
  8. Blann AD, 2011, CARDIOL RES PRACT, DOI 10.4061/2011/394740
  9. Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715
  10. Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007
  11. Carrier M, 2019, NEW ENGL J MED, V380, P711, DOI 10.1056/NEJMoa1814468
  12. Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623
  13. Fernandes CJCD, 2018, J BRAS PNEUMOL, V44, P237, DOI [10.1590/s1806-37562017000000204, 10.1590/S1806-37562017000000204]
  14. Fernandes CJCD, 2017, J BRAS PNEUMOL, V43, P403, DOI [10.1590/S1806-37562017000060002, 10.1590/s1806-37562017000060002]
  15. Fernandes CJCD, 2016, J BRAS PNEUMOL, V42, P146, DOI [10.1590/S1806-37562016042020068, 10.1590/S1806-37562016000000068]
  16. Corrales-Rodriguez L, 2014, THROMB RES, V133, P48, DOI 10.1016/j.thromres.2013.10.042
  17. Coyle K, 2017, THROMB RES, V151, P67, DOI 10.1016/j.thromres.2017.01.007
  18. Delluc A, 2017, J THROMB HAEMOST, V15, P2076, DOI 10.1111/jth.13791
  19. Di Nisio M, 2016, COCHRANE DB SYST REV, V12
  20. Elyamany G, 2014, CLIN MED INSIGHTS-ON, V8, P129, DOI 10.4137/CMO.S18991
  21. Falanga A, 2012, HAMOSTASEOLOGIE, V32, P115, DOI 10.5482/ha-1170
  22. Francis CW, 2015, J THROMB HAEMOST, V13, P1028, DOI 10.1111/jth.12923
  23. Gade IL, 2017, J THROMB HAEMOST, V15, P1567, DOI 10.1111/jth.13752
  24. Hakoum MB, 2018, COCHRANE DB SYST REV, V1
  25. Heit JA, 2016, J THROMB THROMBOLYS, V41, P3, DOI 10.1007/s11239-015-1311-6
  26. Imberti D, 2016, THROMB RES, V140, pS103, DOI 10.1016/S0049-3848(16)30108-6
  27. Jara-Palomares L, 2017, CHEST, V151, P564, DOI 10.1016/j.chest.2016.10.025
  28. Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026
  29. Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x
  30. Khorana AA, 2018, J THROMB HAEMOST, V16, P1891, DOI 10.1111/jth.14219
  31. Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327
  32. Khorana AA, 2014, THROMB RES, V133, pS35, DOI 10.1016/S0049-3848(14)50006-0
  33. Klok FA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00275-2017
  34. Kraaijpoel N, 2018, THROMB HAEMOSTASIS, V118, P1439, DOI 10.1055/s-0038-1667001
  35. Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232
  36. Lee AYY, 2015, JAMA-J AM MED ASSOC, V314, P677, DOI 10.1001/jama.2015.9243
  37. Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313
  38. Lyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351
  39. Mandala M, 2011, ANN ONCOL, V22, pvi85, DOI 10.1093/annonc/mdr392
  40. Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729
  41. Mukai M, 2018, J CARDIOL, V72, P89, DOI 10.1016/j.jjcc.2018.02.011
  42. Napolitano M, 2014, J CLIN ONCOL, V32, P3607, DOI 10.1200/JCO.2013.51.7433
  43. Nielsen C, 2011, HAEMATOL-HEMATOL J, V96, P450, DOI 10.3324/haematol.2010.033191
  44. Pignataro BS, 2017, CLIN APPL THROMB-HEM, V23, P883, DOI 10.1177/1076029616677800
  45. Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108
  46. Prandoni P, 2010, J THROMB HAEMOST, V8, P1126, DOI 10.1111/j.1538-7836.2010.03797.x
  47. Prandoni P, 2016, SEMIN THROMB HEMOST, V42, P884, DOI 10.1055/s-0036-1592335
  48. Puurunen MK, 2016, THROMB RES, V145, P27, DOI 10.1016/j.thromres.2016.06.033
  49. Raskob GE, 2014, THROMB HAEMOSTASIS, V112, P843, DOI 10.1160/TH14-08-0671
  50. Raskob GE, 2018, NEW ENGL J MED, V378, P615, DOI 10.1056/NEJMoa1711948
  51. Robin P, 2017, THROMB RES, V159, P48, DOI 10.1016/j.thromres.2017.08.021
  52. Robin P, 2016, LANCET ONCOL, V17, P193, DOI 10.1016/S1470-2045(15)00480-5
  53. Saba HI, 2003, AM J HEMATOL, V72, P109, DOI 10.1002/ajh.10269
  54. Schulman S, 2000, NEW ENGL J MED, V342, P1953, DOI 10.1056/NEJM200006293422604
  55. Shetty S, 2010, AM J CLIN PATHOL, V134, P82, DOI 10.1309/AJCP7VO4HAIZYATP
  56. Shinagare AB, 2012, LUNG CANCER, V78, P161, DOI 10.1016/j.lungcan.2012.08.007
  57. Stein PD, 2006, AM J MED, V119, P60, DOI 10.1016/j.amjmed.2005.06.058
  58. Sun JM, 2010, LUNG CANCER, V69, P330, DOI 10.1016/j.lungcan.2009.11.015
  59. Trujillo-Santos J, 2008, THROMB HAEMOSTASIS, V100, P435, DOI 10.1160/TH08-02-0125
  60. Turpie AGG, 2017, RES PRACT THROMB HAE, V1, P1
  61. van Es N, 2017, ANN INTERN MED, V167, P410, DOI 10.7326/M17-0868
  62. Vedovati MC, 2015, CHEST, V147, P475, DOI 10.1378/chest.14-0402
  63. Walker AJ, 2013, EUR J CANCER, V49, P1404, DOI 10.1016/j.ejca.2012.10.021
  64. Watson HG, 2015, BRIT J HAEMATOL, V170, P640, DOI 10.1111/bjh.13556
  65. Xavier FD, 2017, J GLOB ONCOL, V3, P15, DOI 10.1200/JGO.2015.002527
  66. Young AM, 2018, J CLIN ONCOL, V36, P2017, DOI 10.1200/JCO.2018.78.8034